Adverse Events Following Quadrivalent Meningococcal Diphtheria Toxoid Conjugate Vaccine (Menactra®) Reported to the Vaccine Adverse Event Reporting System (VAERS), 2005–2016

BACKGROUND: Post marketing safety evaluations of quadrivalent meningococcal diphtheria-toxoid conjugate vaccine (MenACWY-D) have focused on post-vaccination risk of Guillain Barré Syndrome (GBS), adverse events (AEs) after maternal vaccination, and comparative studies with the newer quadrivalent men...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Vaccine
Main Authors: Myers, Tanya R., McNeil, Michael M., Ng, Carmen S., Li, Rongxia, Marquez, Paige L., Moro, Pedro L., Omer, Saad B., Cano, Maria V.
Formato: Artigo
Idioma:Inglês
Publicado: 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7495357/
https://ncbi.nlm.nih.gov/pubmed/32747215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.07.039
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares